FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Abbott has announced that Tandem Diabetes Care’s t:slim X2 insulin pump has become the first automated insulin delivery (AID) system to integrate with its newly available FreeStyle Libre 2 Plus sensor ...